HCW Biologics (HCWB) Earnings Date & Reports

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

HCWB is expected to report earnings to fall 154.05% to -20 cents per share on August 07

HCW Biologics HCWB Stock Earnings Reports

Q2'26

Est.

$-0.20

Q1'26

Beat

by $2.97

Q4'25

Beat

by $1.41

Q3'25

Beat

by $0.28

Q2'25

Missed

by $2.70

The last earnings report on May 14 showed earnings per share of 37 cents, beating the estimate of -259 cents. With 137.38K shares outstanding, the current market capitalization sits at 8.31M.

View a ticker or compare two or three

Compare

HCWB

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for HCWB